GGrantIndex
Sort

27,075 grants matching cholesterol

Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis

$697,873
William James Adams · Riparian Pharmaceuticals, Inc. · R44 · FY2018 · HL

Peer Support for Weight Loss Maintenance

$697,835
Tricia M Leahey · University Of Connecticut Storrs · R01 · FY2017 · DK

HUNTing for myocardial infarction genes by combined genome and exome sequencing

$697,796
Cristen J Willer · University Of Michigan At Ann Arbor · R01 · FY2014 · HL

Regulation of CHCHD6 in Alzheimer's disease

$697,772
Xin Qi · Case Western Reserve University · R01 · FY2025 · AG

T Regulatory Lymphocytes, HDL Function, and Atherosclerosis

$697,733
Catherine C Hedrick · La Jolla Institute For Immunology · R01 · FY2015 · HL

Whole genome sequences in ethnically diverse individuals to comprehensively characterize the genetic mechanisms of dyslipidemias

$697,700
Pradeep Natarajan · Massachusetts General Hospital · R01 · FY2024 · HL

Functional Analysis of Novel Genes in Eye Development and Vision

$697,356
Graeme J Wistow · National Eye Institute · ZIA · FY2013 · EY

Molecular Pharmacology of NKT Cell Agonists

$697,142
Luc Teyton · Scripps Research Institute, The · R01 · FY2013 · AI

Examining the crossover effects of adolescent stress on parent cardiovascular health

$696,945
Melissa A. Lippold · Univ Of North Carolina Chapel Hill · R01 · FY2025 · HL

Mechanisms and functions of host organelle usurpation by intravacuolar Toxoplasma

$696,866
Isabelle Coppens · Johns Hopkins University · R01 · FY2023 · AI

The characterization of Cela2a, a novel disease gene for metabolic syndrome in health and diseases

$696,646
Arya Mani · Yale University · R01 · FY2023 · DK

The Genetic and Molecular Basis of Cholesterol Efflux

$696,639
Anand Kumar Rohatgi · Ut Southwestern Medical Center · R01 · FY2022 · HL

Polypill strategy for the evidence-based management of heart failure with reduced ejection fraction in an underserved patient population

$696,602
Ambarish Pandey · Ut Southwestern Medical Center · R01 · FY2024 · MD

Medications and Weight Gain in PCORnet: The MedWeight Study

$696,572
Jason Perry Block · Harvard Pilgrim Health Care, Inc. · R01 · FY2022 · DK

Aging Intervention Program

$696,557
Rafael De Cabo · National Institute On Aging · ZIA · FY2014 · AG

Ensuring the cultural relevance of Dietary Guidelines diet patterns among African Americans: Increasing dietary quality and reducing type 2 diabetes risk

$696,554
Gabrielle Michelle Turner-McGrievy · University Of South Carolina At Columbia · R01 · FY2023 · DK

Using a SMART design to evaluate remotely delivered, culturally tailored weight loss interventions among Latina breast cancer survivors

$696,497
Heather A Greenlee · Fred Hutchinson Cancer Center · R01 · FY2024 · CA

Effects of Androgen Deprivation Therapy on Preclinical Symptoms of Alzheimer's Disease

$696,482
Matthew S Panizzon · University Of California, San Diego · R01 · FY2019 · AG

Multi-Component Behavioral Intervention for Complex Patients with CVD Risk

$696,268
Richard W Grant · Kaiser Foundation Research Institute · R01 · FY2015 · HL

A Neurosteroid Intervention for Menopausal and Perimenopausal Depression

$696,173
E Sherwood Brown · Ut Southwestern Medical Center · R01 · FY2023 · AG

Novel role of hepatic SEL1L-HRD1 ERAD in bile acid metabolism

$696,090
Ling Qi · University Of Virginia · R01 · FY2024 · DK

Pediatric depression and subsequent cardiac risk factors: a longitudinal study

$695,907
Maria Kovacs · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · HL

Gene-Specific Responses to Exercise in Discordant Twins

$695,858
Paul T Williams · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2006 · HL

Investigating the combined role of APOE4 and ketogenic diets in Alzheimer's disease

$695,802
Joel William Blanchard · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AG

PPAR MEDICATED GENE EXPRESSION IN HIV PATIENTS

$695,754
Marie C Gelato · State University New York Stony Brook · M01 · FY2007 · RR